305 related articles for article (PubMed ID: 7692936)
1. Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy.
Hansen PB; Johnsen HE; Ralfkiaer E; Hansen NE
Br J Haematol; 1993 Aug; 84(4):581-5. PubMed ID: 7692936
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
[TBL] [Abstract][Full Text] [Related]
3. Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors.
Hansen PB; Kjaersgaard E; Johnsen HE; Gram J; Pedersen M; Nikolajsen K; Hansen NE
Br J Haematol; 1993 Sep; 85(1):50-6. PubMed ID: 7504510
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human granulocyte-macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. An open clinical trial.
Piguet D; Chapuis B
Acta Oncol; 1994; 33(6):639-43. PubMed ID: 7946441
[TBL] [Abstract][Full Text] [Related]
6. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
[TBL] [Abstract][Full Text] [Related]
7. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
[TBL] [Abstract][Full Text] [Related]
8. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
Cairo MS; van de Ven C; Mauss D; Kommareddy S; Norris K; Sheikh K; Modanlou H
Biol Neonate; 1991; 59(1):13-21. PubMed ID: 1707685
[TBL] [Abstract][Full Text] [Related]
9. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
[TBL] [Abstract][Full Text] [Related]
12. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
13. Prediction of bone marrow involvement in patients with malignant lymphoma by GM-CSF stimulation test.
Unal A; Güven K; Gürsoy S; Kontas O; Baran L
Int J Hematol; 1996 Oct; 64(3-4):297-300. PubMed ID: 8923797
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.
Stewart AG; Cotterill T; Harris T
Immunology; 1994 May; 82(1):51-6. PubMed ID: 7519173
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
[TBL] [Abstract][Full Text] [Related]
17. Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitro.
Oez S; Birkmann J; Kalden JR
Ann Hematol; 1993 Jan; 66(1):21-5. PubMed ID: 7679293
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of the salvage therapy using pegylated recombinant human granulocyte colony stimulating factor for grade IV neutropenia induced by concurrent chemoradiotherapy].
Wu F; Wang H; Li N; Guo Y; Cheng Y; Liu Q; Yang X; Wan X; Wang J
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):708-12. PubMed ID: 25564064
[TBL] [Abstract][Full Text] [Related]
19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
20. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
